Bills › 91st General Assembly
HF 2009Died when the session ended · January 21, 2026
Relating to manufacturers and distributors of 340B drugs
Sponsored by Rep. Brett Barker (R)
Same legislation: SF 2312
Progress
- IntroducedJanuary 13, 2026
- SubcommitteeJanuary 21, 2026
- Committee—
- Passed House—
- Passed Senate—
- Signed—
Died at end of session The General Assembly adjourned on May 3, 2026. Bills that didn’t pass both chambers died. What’s a funnel?
History
2026 session · second year of the 91st General Assembly
January 21, 2026
Subcommittee recommends passage.
January 14, 2026
Subcommittee: Barker, Bergan and Wilburn. H.J. 97. Journal
January 13, 2026
Introduced, referred to Health and Human Services. H.J. 41. Journal
Meetings
- Wednesday, January 21 · 4:00 PMHealth and Human Services subcommittee · House Lounge 2Official meeting page
Votes
No recorded votes yet.
Lobbyist declarations
For · 5Against · 9Undecided · 6
- Boehringer Ingelheim Pharmaceuticals, Inc.Against
- Bristol Myers Squibb Co.Against
- Eli Lilly & Co.Against
- Genentech, Inc., A Member of the Roche GroupAgainst
- Iowa Biotechnology AssociationAgainst
- Merck Sharp & Dohme LLCAgainst
- Novartis Services, Inc.Against
- Novo NordiskAgainst
- Pharmaceutical Research and Manufacturers of America (PhRMA)Against
- Iowa Hospital AssociationFor
- Iowa Integrated Health Planning and Advisory CouncilFor
- Iowa Medical SocietyFor
- Iowa Pharmacy AssociationFor
- Iowa Primary Care AssociationFor
- Bristol Myers Squibb Co.Undecided
- Healthcare Distribution Alliance c/o MultiState Associates LLCUndecided
- Iowa Board of RegentsUndecided
- Iowa Department of Inspections, Appeals, and LicensingUndecided
- Iowa Insurance DivisionUndecided
- Wellmark, Inc.Undecided
Grouped by organization. Lobbying overview →